-- The London Proteomics Discussion Group --
Proteomics seminar series for the South East
Proteomics seminar series for the South East
We are a free, local proteomics seminar series in the South East,
with a focus towards networking, discussion and supporting early career researchers.
The LPDG...
was founded to bring together the large community of proteomics scientists all working in and around London. We aim to provide a space for discussion, with a focus on methods and early career researchers (two fundamental building blocks of good research!), on all topics related to proteomics. The meetings comprise of research talks framed by a proteomics methods challenge, lunch, refreshments and pizza - they are free to attend thanks to sponsorship.
Meeting Dates:
Happy to be here on Bluesky. We'll be doing a little series of "meet the committee members" over the next few weeks, having just held our elections for new members. Look out for the old and new faces coming soon 😊
— London Proteomics Discussion Group (@lpdg.bsky.social) December 8, 2024 at 7:00 PM
These seminars would not be possible without our amazing sponsors.
If you are interested in sponsoring an LPDG seminar,
please get in touch at sponsor@londonproteomics.co.uk
for 15th October 2026 Time 12:00
Would you like to present at an LPDG meeting? Email: speaker@londonproteomics.co.uk
Research presentations from:
Keshava heads the Proteomics Core Laboratory at the MRC Laboratory of Medical Sciences, where he collaborates with research groups to enable discovery and translational research.
TBC
Matilda is a final year PhD student in the Ye lab at Imperial funded by the President's PhD scholarship, whose work uses post-mortem brain tissue and iPSC-derived neuron models to investigate the role of the ubiquitin-proteasome system in the development of tauopathies.
Dr Francesca Roberston completed her PhD and Post Doc at Royal Holloway before becoming Experimental Officer to support staff and Students with Mass spectrometry experiments at University of Surrey. She moved to work into Industry and Protein Metrology research at LGC. She joined the new start-up company Guilford Street Laboratories in March 2025 and leads ImmunoTADA™ IVD for detection of anti-drug antibodies in Fabry disease. She works with NHS partners at the Neurometabolic Unit, UCLH to develop the assay to a clinical standard.